EmoPulse, an early-stage deep-tech startup developing an AI-driven interpretive layer for biometric and cognitive state analysis, is currently targeting a €2 million seed funding round to support the expansion of its on-device intelligence platform. The company is building what it describes as a five-layer ontological system that processes real-time human behavioral and physiological signals to adapt artificial intelligence behavior based on user cognitive states.

According to publicly available company information, EmoPulse’s platform captures and interprets multiple biometric inputs—including micro-expressions, gaze movement, and physiological indicators—to construct a real-time “state vector” representing human emotional and cognitive conditions. This data is processed entirely on-device, without cloud dependency, positioning the system for use in sensitive or secure environments where data privacy and latency are critical.

The startup states that its technology is designed for high-stakes environments such as defense systems, healthcare monitoring, automotive safety, and enterprise AI governance. Its architecture is intended to help AI systems dynamically adjust decision-making, tone, and output based on detected human stress levels or cognitive overload.

EmoPulse has outlined a seed funding goal of approximately €2 million to accelerate development of its edge-based AI infrastructure, expand pilot deployments, and refine its multi-layer reasoning engine. However, despite this stated fundraising target, the company has not publicly confirmed any completed venture capital investment or disclosed institutional participation in its funding round.

There are currently no verified institutional investors, angel investors, or accelerator programs publicly associated with EmoPulse. As a result, no investor names can be accurately identified or linked to the company’s funding activity. Any attempt to attribute funding to specific investors would be speculative and not supported by publicly available records.

In contrast, comparable companies in adjacent sectors such as AI infrastructure and deep-tech often secure seed backing from established venture firms. For example, firms like Founders Fund, Andreessen Horowitz, and General Catalyst are active in early-stage AI investments globally. However, none of these firms have been publicly linked to EmoPulse.

The company’s approach is positioned within the emerging category of “human-state AI,” which combines computer vision, biometric analytics, and adaptive machine learning systems. This segment is attracting increasing attention across the AI ecosystem as companies explore ways to make systems more responsive to human cognitive and emotional signals.

EmoPulse continues to develop its core technology stack, which it describes as a five-layer architecture designed to translate raw sensor data into structured cognitive state representations. These outputs are then used to influence AI system behavior in real time, enabling adaptive responses in mission-critical applications.

While the company has clearly articulated its fundraising objectives and technical roadmap, its current funding status remains in the pre-seed or seed-raise stage without publicly disclosed investors or completed institutional backing.

As of now, EmoPulse remains an early-stage deep-tech startup with a stated €2 million seed target, but no verified investors or completed funding round in public records.

Related Articles